Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study

BACKGROUND AND AIMS: The efficacy and safety of systemic atezolizumab and bevacizumab (atezo/bev) in treatment of patients with unresectable hepatocellular carcinoma (HCC) have been demonstrated. However, the efficacy of this treatment in patients with HCC and extrahepatic portal vein tumor thrombus...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kang, Xiang, Yan-Jun, Yu, Hong-Ming, Cheng, Yu-Qiang, Liu, Zong-Han, Zhong, Jing-Ya, Feng, Shuang, Ni, Qian-Zhi, Zhu, Hong-Fei, Pan, Wei-Wei, Li, Jing-Jing, Liang, Chao, Zhou, Hong-Kun, Meng, Yan, Lau, Wan Yee, Cheng, Shu-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978499/
https://www.ncbi.nlm.nih.gov/pubmed/36875125
http://dx.doi.org/10.3389/fimmu.2023.1107542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978499/
https://www.ncbi.nlm.nih.gov/pubmed/36875125
http://dx.doi.org/10.3389/fimmu.2023.1107542

Ejemplares similares